MétaCan
Menu
Back to cohort
Record W2489035057 · doi:10.18632/oncotarget.10819

Targeting multidrug-resistant ovarian cancer through estrogen receptor α dependent ATP depletion caused by hyperactivation of the unfolded protein response

2016· article· en· W2489035057 on OpenAlexaboutno aff
Xiaobin Zheng, Neal Andruska, Michael J. Lambrecht, Sisi He, Amadeo M. Parissenti, Paul J. Hergenrother, Erik R. Nelson, David J. Shapiro

Bibliographic record

VenueOncotarget · 2016
Typearticle
Languageen
FieldMedicine
TopicDrug Transport and Resistance Mechanisms
Canadian institutionsnot available
FundersNational Institutes of HealthUniversity of Illinois at Urbana-ChampaignU.S. Department of Defense
KeywordsCancer researchHyperactivationOvarian cancerUnfolded protein responseMedicineMultiple drug resistanceEstrogen receptorEstrogenCancerPharmacologyEndocrinologyBiologyInternal medicineDrug resistanceCell biologyEndoplasmic reticulumBreast cancer

Abstract

fetched live from OpenAlex

// Xiaobin Zheng 1 , Neal Andruska 1,6 , Michael J. Lambrecht 2 , Sisi He 3 , Amadeo Parissenti 4 , Paul J. Hergenrother 2 , Erik R. Nelson 3,5 and David J. Shapiro 1,5,6 1 Department of Biochemistry University of Illinois, Urbana, IL, USA 2 Department of Chemistry, University of Illinois, Urbana, IL, USA 3 Department of Molecular Integrative Physiology, University of Illinois, Urbana, IL, USA 4 Cancer Research Program, Advanced Medical Research Institute of Canada, Sudbury, ON, Canada 5 University of Illinois Cancer Center, Urbana, IL, USA 6 College of Medicine, University of Illinois, Urbana, IL, USA Correspondence to: David J. Shapiro, email: // Keywords : ERα biomodulator; ATP depletion; unfolded protein response (UPR); MDR1/P-glycoprotein/ABCB1; OVCAR-3 ovarian cancer Received : May 02, 2016     Accepted : July 10, 2016     Epub: July 24, 2016     Published: March 13, 2018 Abstract Ovarian cancers often recur and tumors acquire resistance to chemotherapy due to overexpression of the ATP-dependent efflux pump, multidrug resistance protein 1 (MDR1/P-glycoprotein/ABCB1). Nontoxic small molecule inhibitors targeting MDR1 have remained largely elusive. Instead, in a novel application of our recently described estrogen receptor α (ERα) biomodulator, BHPI, we targeted MDR1’s substrate, ATP. BHPI depletes intracellular ATP and nearly blocks MDR1-mediated drug efflux in ovarian cancer cells by inducing toxic hyperactivation of the endoplasmic reticulum stress sensor, the unfolded protein response (UPR). BHPI increased sensitivity of MDR1 overexpressing multidrug resistant OVCAR-3 ovarian cancer cells to killing by paclitaxel by >1,000 fold. BHPI also restored doxorubicin sensitivity in OVCAR-3 cells and in MDR1 overexpressing breast cancer cells. In an orthotopic OVCAR-3 xenograft model, paclitaxel was ineffective and the paclitaxel-treated group was uniquely prone to form large secondary tumors in adjacent tissue. BHPI alone strongly reduced tumor growth. Notably, tumors were undetectable in mice treated with BHPI plus paclitaxel. Compared to control ovarian tumors, after the combination therapy, levels of the plasma ovarian cancer biomarker CA125 were at least several hundred folds lower; moreover, CA125 levels progressively declined to undetectable. Targeting MDR1 through UPR-dependent ATP depletion represents a promising therapeutic strategy.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.051
Threshold uncertainty score0.531

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.013
GPT teacher head0.256
Teacher spread0.243 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations32
Published2016
Admission routes1
Has abstractyes

Explore more

Same venueOncotargetSame topicDrug Transport and Resistance MechanismsFrench-language works237,207